Stephen R. Petteway
Chief Tech/Sci/R&D Officer at Talecris Biotherapeutics Holdings Corp.
Profile
Stephen R.
Petteway is currently the Executive Vice President-Research & Development at Talecris Biotherapeutics Holdings Corp.
He previously held positions as Chairman at Plasma Protein Therapeutics Association, Director at Entegrion, Inc., Director-Drug Development at Cato Research LLC, Vice President at Trimeris, Inc., and Senior Vice President-Research & Development at Grifols Therapeutics, Inc. He holds a doctorate degree from The University of Alabama and an undergraduate degree from the University of South Florida.
Stephen R. Petteway active positions
Companies | Position | Start |
---|---|---|
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Chief Tech/Sci/R&D Officer | 01/04/2005 |
Former positions of Stephen R. Petteway
Companies | Position | End |
---|---|---|
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Chairman | - |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Entegrion, Inc.
Entegrion, Inc. Pharmaceuticals: MajorHealth Technology Entegrion, Inc. develops biological technologies, drugs, and pharmaceuticals. It applies public and private funds to design, develop, and deliver products that address unmet needs in military healthcare and have commercial applications. The company was founded by Arthur P. Bode in 2002 and is headquartered in Durham, NC. | Director/Board Member | - |
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | Chief Tech/Sci/R&D Officer | - |
Training of Stephen R. Petteway
The University of Alabama | Doctorate Degree |
University of South Florida | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
Entegrion, Inc.
Entegrion, Inc. Pharmaceuticals: MajorHealth Technology Entegrion, Inc. develops biological technologies, drugs, and pharmaceuticals. It applies public and private funds to design, develop, and deliver products that address unmet needs in military healthcare and have commercial applications. The company was founded by Arthur P. Bode in 2002 and is headquartered in Durham, NC. | Health Technology |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Commercial Services |
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Commercial Services |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | Health Technology |
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Stock Market
- Insiders
- Stephen R. Petteway